AI-generated summary
The authors randomized 21 mastectomized women taking tamoxifen or aromatase inhibitors to red laser intravascular irradiation of blood at 660 nm on the carotid artery or a placebo, measuring ultrasensitive C-reactive protein and homocysteine monthly for four months. They report no statistical difference in C-reactive protein between groups, but a significant between-group difference in homocysteine in the third and fourth months, which they associate with possible cardiovascular benefit.
- Participants
- 21
- Who or what was studied
- Mastectomized women taking hormonal blockers (tamoxifen or aromatase inhibitors) for cancer treatment
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports a small sample of 21 patients split into two groups of 12 and 9, and does not report the cardiovascular outcome directly.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Placebo-controlled, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.